Clinical Factors Associated with Progression in Previously Treated Patients with Metastatic NSCLC on ANTI-PD-1 Therapy

被引:0
|
作者
Randall, M. [1 ]
Kollipara, R. [1 ]
Basu, S. [2 ]
Borgia, J. [3 ]
Batus, M. [4 ]
Bonomi, P. [4 ]
Tarhoni, I. [3 ]
Fughhi, I. [5 ]
Fidler, M. [4 ]
机构
[1] Rush Univ, Med Ctr, Internal Med, Chicago, IL 60612 USA
[2] Rush Univ, Med Ctr, Biostat, Chicago, IL 60612 USA
[3] Rush Univ, Med Ctr, Cell & Mol Med, Chicago, IL 60612 USA
[4] Rush Univ, Med Ctr, Hematol Oncol, Chicago, IL 60612 USA
[5] Rush Univ, Med Ctr, Chicago, IL 60612 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P1.05
引用
收藏
页码:S1142 / S1142
页数:1
相关论文
共 50 条
  • [1] Efficacy and safety of anti-PD-1 therapy plus anlotinib in previously treated advanced NSCLC
    Lv, X.
    Wang, L.
    Su, S.
    Li, R.
    Liu, B.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S1009 - S1009
  • [2] Entinostat plus Pembrolizumab in Patients with Metastatic NSCLC Previously Treated with Anti-PD-(L)1 Therapy
    Hellmann, Matthew D.
    Janne, Pasi A.
    Opyrchal, Mateusz
    Hafez, Navid
    Raez, Luis E.
    Gabrilovich, Dmitry, I
    Wang, Fang
    Trepel, Jane B.
    Lee, Min-Jung
    Yuno, Akira
    Lee, Sunmin
    Brouwer, Susan
    Sankoh, Serap
    Wang, Lei
    Tamang, David
    Schmidt, Emmett, V
    Meyers, Michael L.
    Ramalingam, Suresh S.
    Shum, Elaine
    Ordentlich, Peter
    [J]. CLINICAL CANCER RESEARCH, 2021, 27 (04) : 1019 - 1028
  • [3] Immuno-SABR Reboots the Immune Response in Patients with Metastatic NSCLC and Melanoma in Progression to Anti-PD-1 Therapy
    Chicas Sett, R.
    Zafra Martin, J.
    Castilla Martinez, J. F.
    Morales, I.
    Rodriguez, D.
    Benitez, G.
    Lloret, M.
    Lara, P. C.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S73 - S74
  • [4] Lichenoid Dermatitis in Three Patients with Metastatic Melanoma Treated with Anti-PD-1 Therapy
    Joseph, Richard W.
    Cappel, Mark
    Goedjen, Brent
    Gordon, Matthew
    Kirsch, Brandon
    Gilstrap, Cheryl
    Bagaria, Sanjay
    Jambusaria-Pahlajani, Anokhi
    [J]. CANCER IMMUNOLOGY RESEARCH, 2015, 3 (01) : 18 - 22
  • [5] Discontinuation of Anti-PD-1/PD-L1 Antibody Therapy in the Absence of Disease Progression: Clinical Outcomes in Advanced NSCLC
    Minatta, N.
    Bluthgen, M.
    Rizzo, M.
    Rizzi, M.
    Kuzminin, A.
    Recondo, G., Jr.
    Faura, M.
    Naveira, M.
    Perfetti, A.
    Cerini, M.
    Lupinacci, L.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S741 - S742
  • [6] Responses and Durability in NSCLC Treated With Pegilodecakin and Anti-PD-1
    Garon, E.
    Wong, D.
    Schneider, J.
    Aliumaily, R.
    Korn, W.
    Infante, J.
    Patel, M.
    Autio, K.
    Papadopoulos, K.
    Naing, A.
    Gabrail, N.
    Munster, P.
    Goldman, J.
    Hung, A.
    Van Vlasselaer, P.
    Leveque, J.
    Oft, M.
    Spigel, D.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S366 - S367
  • [7] Circulating IL-6 is associated with disease progression in BRAFwt metastatic melanoma patients receiving anti-PD-1 therapy
    Martinovic, Katarina Mirjacic
    Vuletic, Ana
    Miletic, Nevena Tisma
    Matkovic, Suzana
    Gavrilovic, Dusica
    Ninkovic, Aleksandra
    Jurisic, Vladimir
    Babovic, Nada
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2024, 77 (05) : 343 - 351
  • [8] Palliative Radiation Therapy for Vertebral Metastases and Metastatic Cord Compression in Patients Treated With Anti-PD-1 Therapy
    Fareed, Muhammad Mohsin
    Pike, Luke R. G.
    Bang, Andrew
    Mai Anh Huynh
    Taylor, Allison
    Spektor, Alexander
    Awad, Mark M.
    Ott, Patrick A.
    Krishnan, Monica
    Balboni, Tracy A.
    Schoenfeld, Jonathan D.
    [J]. FRONTIERS IN ONCOLOGY, 2019, 9
  • [9] Palliative Radiation Therapy for Vertebral Metastases and Metastatic Cord Compression in Patients Treated with Anti-PD-1 Therapy
    Fareed, M. M.
    Pike, L. R. G.
    Bang, A.
    Taylor, A.
    Spektor, A.
    Awad, M. M.
    Ott, P.
    Krishnan, M. S.
    Balboni, T. A.
    Schoenfeld, J. D.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E217 - E217
  • [10] Intratumoral CD16± Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
    Lee, Hansol
    Ferguson, Angela L.
    Quek, Camelia
    Vergara, Ismael A.
    daSilva, Ines Pires
    Allen, Ruth
    Gide, Tuba Nur
    Conway, Jordan W.
    Koufariotis, Lambros T.
    Hayward, Nicholas K.
    Waddell, Nicola
    Carlino, Matteo S.
    Menzies, Alexander M.
    Saw, Robyn P. M.
    Shklovskaya, Elena
    Rizos, Helen
    Lo, Serigne
    Scolyer, Richard A.
    V. Long, Georgina
    Palendira, Umaimaintha
    Wilmott, James S.
    [J]. CLINICAL CANCER RESEARCH, 2023, 29 (13) : 2513 - 2524